Literature DB >> 30760000

Placental Growth Factor as an Indicator of Maternal Cardiovascular Risk After Pregnancy.

Laura Benschop1, Sarah Schalekamp-Timmermans1, Zoe A Broere-Brown1, Jeanine E Roeters van Lennep2, Vincent W V Jaddoe3,4, Jolien W Roos-Hesselink5, M Kamran Ikram6, Eric A P Steegers1, James M Roberts7,8, Robin E Gandley7.   

Abstract

BACKGROUND: Angiogenic placental growth factor (PlGF) concentrations rise during pregnancy, peaking at the end of midpregnancy. Low PlGF concentrations during pregnancy are associated with pregnancy complications with recognized later-life cardiovascular risk. We hypothesized that low PlGF concentrations, especially in midpregnancy, identify not only a subset of women at risk for pregnancy complications but also women with greater cardiovascular risk factor burden after pregnancy regardless of pregnancy outcome.
METHODS: In a population-based prospective cohort study of 5475 women, we computed gestational age-adjusted multiples of the medians of early pregnancy and midpregnancy PlGF concentrations. Information on pregnancy complications (preeclampsia, small for gestational age, and spontaneous preterm birth) was obtained from hospital registries. Six years after pregnancy, we measured maternal systolic and diastolic blood pressures, cardiac structure (aortic root diameter, left atrial diameter, left ventricular mass, and fractional shortening), carotid-femoral pulse wave velocity, and central retinal arteriolar and venular calibers. Blood pressure was also measured 9 years after pregnancy.
RESULTS: Women were on average 29.8 (SD, 5.2) years of age in pregnancy, were mostly European (55.2%), and 14.8% developed a pregnancy complication. Quartile analysis showed that especially women with midpregnancy PlGF in the lowest quartile (the low-PlGF subset) had a larger aortic root diameter (0.40 mm [95% CI, 0.08-0.73]), left atrial diameter (0.34 mm [95% CI, -0.09 to 0.78]), left ventricular mass (4.6 g [95% CI, 1.1-8.1]), and systolic blood pressure (2.3 mm Hg [95% CI, 0.93-3.6]) 6 years after pregnancy than women with the highest PlGF. Linear regression analysis showed that higher midpregnancy PlGF concentrations were associated with a smaller aortic root diameter (-0.24 mm [95% CI, -0.39 to -0.10]), smaller left atrial diameter (-0.75 mm [95% CI, -0.95 to -0.56]), lower left ventricular mass (-3.9 g [95% CI, -5.5 to -2.3]), and lower systolic blood pressure (-1.1 mm Hg [95% CI, -1.7 to -0.46]). These differences persisted after the exclusion of women with complicated pregnancies.
CONCLUSIONS: Women with low PlGF in midpregnancy have a greater aortic root diameter, left atrial diameter, and left ventricular mass and higher systolic blood pressure 6 and 9 years after pregnancy compared to women with higher PlGF, including women with uncomplicated pregnancies. The pathophysiological implications of lower PlGF concentrations in midpregnancy might provide insight into the identification of pathways contributing to greater cardiovascular risk factor burden.

Entities:  

Keywords:  cardiovascular diseases; placenta growth factor; pre-eclampsia; pregnancy outcome; risk factors

Mesh:

Substances:

Year:  2019        PMID: 30760000      PMCID: PMC6443459          DOI: 10.1161/CIRCULATIONAHA.118.036632

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  48 in total

1.  Endothelial function progressively deteriorates during normal pregnancy.

Authors:  Kohei Fujita; Keiji Tatsumi; Eiji Kondoh; Yoshitsugu Chigusa; Haruta Mogami; Masatoshi Fujita; Ikuo Konishi
Journal:  Hypertens Pregnancy       Date:  2013-05       Impact factor: 2.108

Review 2.  Arterial stiffness and hypertension: chicken or egg?

Authors:  Gary F Mitchell
Journal:  Hypertension       Date:  2014-08       Impact factor: 10.190

3.  Placental growth factor influences maternal cardiovascular adaptation to pregnancy in mice.

Authors:  Kristiina L Aasa; Bruno Zavan; Rayana L Luna; Philip G Wong; Nicole M Ventura; M Yat Tse; Peter Carmeliet; Michael A Adams; Stephen C Pang; B Anne Croy
Journal:  Biol Reprod       Date:  2014-12-23       Impact factor: 4.285

4.  Preeclampsia is associated with persistent postpartum cardiovascular impairment.

Authors:  Karen Melchiorre; George Ross Sutherland; Marco Liberati; Basky Thilaganathan
Journal:  Hypertension       Date:  2011-08-15       Impact factor: 10.190

5.  Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history.

Authors:  A Tsiakkas; N Duvdevani; A Wright; D Wright; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2015-04-01       Impact factor: 7.299

6.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

7.  An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease.

Authors:  Takaki Matsumoto; Shiro Uemura; Yukiji Takeda; Masaru Matsui; Sadanori Okada; Taku Nishida; Tsunenari Soeda; Satoshi Okayama; Satoshi Somekawa; Ken-Ichi Ishigami; Kenji Onoue; Hiroyuki Kawata; Rika Kawakami; Manabu Horii; Yoshihiko Saito
Journal:  Intern Med       Date:  2013-05-15       Impact factor: 1.271

8.  Circulating angiogenic factors and the risk of preeclampsia.

Authors:  Richard J Levine; Sharon E Maynard; Cong Qian; Kee-Hak Lim; Lucinda J England; Kai F Yu; Enrique F Schisterman; Ravi Thadhani; Benjamin P Sachs; Franklin H Epstein; Baha M Sibai; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

9.  Insights into cardiac alterations after pre-eclampsia: an echocardiographic study.

Authors:  R Orabona; E Vizzardi; E Sciatti; I Bonadei; A Valcamonico; M Metra; T Frusca
Journal:  Ultrasound Obstet Gynecol       Date:  2017-01       Impact factor: 7.299

10.  Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.

Authors:  Frank T Spradley; Adelene Y Tan; Woo S Joo; Garrett Daniels; Paul Kussie; S Ananth Karumanchi; Joey P Granger
Journal:  Hypertension       Date:  2016-02-01       Impact factor: 10.190

View more
  9 in total

1.  Postnatal Enalapril to Improve Cardiovascular Function Following Preterm Preeclampsia (PICk-UP):: A Randomized Double-Blind Placebo-Controlled Feasibility Trial.

Authors:  Laura Ormesher; Suzanne Higson; Matthew Luckie; Stephen A Roberts; Heather Glossop; Andrew Trafford; Elizabeth Cottrell; Edward D Johnstone; Jenny E Myers
Journal:  Hypertension       Date:  2020-10-05       Impact factor: 10.190

2.  Previous preeclampsia and its association with the future development of cardiovascular diseases: a systematic review and meta-analysis.

Authors:  Eduardo Carvalho de Arruda Veiga; Paulo Ricardo Higassiaraguti Rocha; Leonardo L Caviola; Viviane Cunha Cardoso; Fabricio da Silva Costa; Maria da Conceição Pereira Saraiva; Marco Antonio Barbieri; Heloisa Bettiol; Ricardo Carvalho Cavalli
Journal:  Clinics (Sao Paulo)       Date:  2021-01-20       Impact factor: 2.365

Review 3.  Vascular Dysfunction in Preeclampsia.

Authors:  Megan A Opichka; Matthew W Rappelt; David D Gutterman; Justin L Grobe; Jennifer J McIntosh
Journal:  Cells       Date:  2021-11-06       Impact factor: 7.666

Review 4.  Long-Term Consequences of Placental Vascular Pathology on the Maternal and Offspring Cardiovascular Systems.

Authors:  Marisa Benagiano; Salvatore Mancuso; Jan J Brosens; Giuseppe Benagiano
Journal:  Biomolecules       Date:  2021-11-03

5.  Prediction performance of serum placental growth factor (PLGF) human chorionic gonadotropin β (β-hCG) and PAPP-A levels in early pregnancy for pregnancy outcomes.

Authors:  Xiao Guo; Feng Wang; Jing Li; Zhankun Guo; Jing Wang
Journal:  Pak J Med Sci       Date:  2022 Sep-Oct       Impact factor: 2.340

Review 6.  Vision for Improving Pregnancy Health: Innovation and the Future of Pregnancy Research.

Authors:  James M Roberts; Dominik Heider; Lina Bergman; Kent L Thornburg
Journal:  Reprod Sci       Date:  2022-05-09       Impact factor: 2.924

Review 7.  Placental Dysfunction in Assisted Reproductive Pregnancies: Perinatal, Neonatal and Adult Life Outcomes.

Authors:  Claudio Manna; Valentina Lacconi; Giuseppe Rizzo; Antonino De Lorenzo; Micol Massimiani
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923

8.  Placental Pathology as a Tool to Identify Women for Postpartum Cardiovascular Risk Screening following Preeclampsia: A Preliminary Investigation.

Authors:  Samantha J Benton; Erika E Mery; David Grynspan; Laura M Gaudet; Graeme N Smith; Shannon A Bainbridge
Journal:  J Clin Med       Date:  2022-03-13       Impact factor: 4.241

Review 9.  Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders.

Authors:  Sarosh Rana; Suzanne D Burke; S Ananth Karumanchi
Journal:  Am J Obstet Gynecol       Date:  2020-10-20       Impact factor: 8.661

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.